← Leaderboards
Alexander Federation
Talus Bioscience, Inc.
$4,739,890
Attributed
$4,739,890
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,739,890 · 4
By mechanism
R44$3,951,023 · 2
R42$455,000 · 1
R43$333,867 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Sodium Chloride”
- Annette Reingart Von Delft · Sloan-Kettering Inst Can Research$2,995,716
- Daniel Levy · Phoenix Pharmalabs, Inc.$2,894,503
- James M Balkovec · Hackensack University Medical Center$2,556,551
- Timothy R. Brick · Pennsylvania State University, The$2,120,222
- Robert Lippert · Kuda Therapeutics, Inc.$2,050,000
- Sierra E Carter · Emory University$2,028,380
Research focus
Sodium ChlorideTranscription FactorProteomeSmall MoleculeTechnologyInhibitorOncogenicProteinsMass Spectrum AnalysisProteomicsTalusGenomeClinical TrialsInflammationNuclearChromatinPeptidesPharmaceutical PreparationsDrug DevelopmentDrug DiscoveryMalignant NeoplasmsCellsGene ExpressionCofactor
Grant awards (7)
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors$821,779
R44 · FY2025 · TR · contact PI
Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer$1,000,000
R44 · FY2024 · CA · contact PI
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors$821,779
R44 · FY2024 · TR · contact PI
Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer$1,000,000
R44 · FY2023 · CA · contact PI
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors$307,465
R44 · FY2023 · TR · contact PI
Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer$455,000
R42 · FY2022 · CA · contact PI
Illuminating the "dark" kinases - effects on proteome translocation and chromatin binding$333,867
R43 · FY2022 · TR · contact PI